DalsnaFinance › Analyst accuracy › BTIG › BSX target
BTIG cuts Boston Scientific stock price target on weaker outlook
BTIG lowered its price target on Boston Scientific Corp. (NYSE:BSX) to $60 from $65 while maintaining a Buy rating on the stock.
A fact about what BTIG published, as reported by Investing.com, not a recommendation from Dalsna Finance; BTIG is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.